Stock DNA
Pharmaceuticals & Biotechnology
CNY 2,463 Million (Small Cap)
NA (Loss Making)
NA
0.00%
0.31
-13.54%
2.64
Revenue and Profits:
Net Sales:
109 Million
(Quarterly Results - Mar 2026)
Net Profit:
1 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
11.11%
0%
11.11%
6 Months
6.13%
0%
6.13%
1 Year
21.29%
0%
21.29%
2 Years
-1.75%
0%
-1.75%
3 Years
-2.6%
0%
-2.6%
4 Years
2.04%
0%
2.04%
5 Years
-26.11%
0%
-26.11%
Chengdu Huasun Technology Group Inc., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-2.86%
EBIT Growth (5y)
-211.36%
EBIT to Interest (avg)
29.29
Debt to EBITDA (avg)
6.98
Net Debt to Equity (avg)
0.49
Sales to Capital Employed (avg)
0.56
Tax Ratio
53.47%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
4.47%
ROE (avg)
3.81%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
2.45
EV to EBIT
-47.12
EV to EBITDA
-271.63
EV to Capital Employed
2.13
EV to Sales
3.90
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-4.51%
ROE (Latest)
-8.44%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bearish
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY
Mar'26
Mar'25
Change(%)
Net Sales
109.30
126.90
-13.87%
Operating Profit (PBDIT) excl Other Income
6.00
-2.30
360.87%
Interest
3.40
4.70
-27.66%
Exceptional Items
0.00
0.00
Consolidate Net Profit
0.90
-14.50
106.21%
Operating Profit Margin (Excl OI)
55.00%
-102.80%
15.78%
USD in Million.
Net Sales
YoY Growth in quarter ended Mar 2026 is -13.87% vs -29.22% in Mar 2025
Consolidated Net Profit
YoY Growth in quarter ended Mar 2026 is 106.21% vs -453.66% in Mar 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
540.60
856.90
-36.91%
Operating Profit (PBDIT) excl Other Income
-78.30
49.60
-257.86%
Interest
20.50
20.70
-0.97%
Exceptional Items
-175.70
3.90
-4,605.13%
Consolidate Net Profit
-346.10
-7.40
-4,577.03%
Operating Profit Margin (Excl OI)
-234.50%
6.80%
-24.13%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is -36.91% vs -14.09% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is -4,577.03% vs -125.00% in Dec 2024
About Chengdu Huasun Technology Group Inc., Ltd. 
Chengdu Huasun Technology Group Inc., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






